<DOC>
	<DOCNO>NCT00154414</DOCNO>
	<brief_summary>This trial conduct Japan . The aim research trial evaluate effect treatment liraglutide placebo blood glucose control 14 week Japanese subject type 2 diabetes . Liraglutide placebo administer injection daily evening . The trial multi-national trial treatment conceal participate subject , investigator sponsor . Treatment allocation random equal chance assign group .</brief_summary>
	<brief_title>Effect Liraglutide Blood Glucose Control Japanese Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Subjects diagnose type 2 diabetes treat diet therapy without single oral drug therapy 7.0 % = &lt; HbA1c &lt; 10.0 % Body Mass Index ( BMI ) &lt; 30.0 kg/m^2 Subjects treat thiazolidinediones insulin Subjects serious medical condition</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>